Medicare Enrolled
Dr. Nuruddin Jooma, M.D.
Medical Oncology · Clearwater, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jooma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jooma? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jooma
Dr. Nuruddin Jooma is a medical oncology in Clearwater, FL, with 18 years in practice. Based on federal Medicare data, Dr. Jooma performed 349,349 Medicare services across 4,726 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jooma received a total of $17,984 from 87 pharmaceutical and/or device companies across 619 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jooma is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 4% volume in FL$ $17,984 industry payments
Medicare Practice Summary
Medicare Utilization ↗349,349
Medicare services
Top 4% in FL for medical oncology
4,726
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~19,408 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 125,460 | $0 | $4 |
| Filgrastim injection (Nivestym) for white blood cells | 49,440 | $0 | $1 |
| Filgrastim injection (Zarxio) for white blood cells | 40,020 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 28,400 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 23,010 | $1 | $5 |
| Oxaliplatin chemotherapy injection | 18,400 | $0 | $12 |
| Epoetin alfa injection (Procrit) for anemia | 15,380 | $6 | $23 |
| Iron sucrose injection (Venofer) | 10,200 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 7,380 | $18 | $51 |
| Dexamethasone injection (steroid) | 4,390 | $0 | $3 |
| Immune globulin infusion (Gammagard) | 4,226 | $36 | $108 |
| Complete blood count (CBC) with differential | 2,998 | $8 | $29 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 2,975 | $23 | $185 |
| Blood draw (venipuncture) | 2,869 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,590 | $1 | $28 |
| Drug injection, under skin or into muscle | 1,272 | $11 | $69 |
| Office visit, established patient (30-39 min) | 1,074 | $95 | $339 |
| Office visit, established patient (20-29 min) | 812 | $66 | $239 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 810 | $22 | $84 |
| Anti-nausea injection (ondansetron/Zofran) | 804 | $0 | $9 |
| Injection, fluorouracil, 500 mg | 649 | $2 | $7 |
| Administration of chemotherapy into vein, 1 hour or less | 636 | $97 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 462 | $47 | $189 |
| Injection of additional new drug or substance into vein | 421 | $12 | $61 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 385 | $3 | $205 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 379 | $1 | $6 |
| Injection, cisplatin, powder or solution, 10 mg | 348 | $2 | $13 |
| Infusion into a vein for hydration, each additional hour | 268 | $10 | $42 |
| Injection, carboplatin, 50 mg | 257 | $2 | $41 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 250 | $3 | $11 |
| Injection, diphenhydramine hcl, up to 50 mg | 240 | $1 | $3 |
| Administration of chemotherapy into vein, each additional hour | 224 | $22 | $79 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 210 | $15 | $56 |
| Infusion, normal saline solution , 1000 cc | 203 | $2 | $7 |
| Injection, zoledronic acid, 1 mg | 201 | $7 | $69 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 199 | $17 | $59 |
| Injection, magnesium sulfate, per 500 mg | 192 | $1 | $2 |
| Administration of additional new drug or substance into vein, 1 hour or less | 185 | $48 | $178 |
| New patient office visit (45-59 min) | 119 | $123 | $453 |
| Injection of drug or substance into vein | 117 | $28 | $156 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 98 | $52 | $206 |
| Red blood count, automated test | 93 | $4 | $10 |
| Infusion into a vein for hydration, 31-60 minutes | 92 | $24 | $156 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 92 | $24 | $89 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 92 | $128 | $637 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 76 | $134 | $562 |
| Automated urinalysis | 66 | $2 | $8 |
| Administration of additional new drug or substance into vein using push technique | 66 | $41 | $170 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 57 | $1 | $7 |
| Office visit, established patient, complex (40-54 min) | 55 | $137 | $474 |
| Drawing of blood for a medical problem | 24 | $61 | $277 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 24 | $4 | $15 |
| Initial hospital admission, high complexity | 19 | $133 | $556 |
| Office visit, established patient (10-19 min) | 15 | $44 | $147 |
| Transitional care management services for problem of high complexity | 14 | $205 | $722 |
| New patient office visit (30-44 min) | 11 | $72 | $298 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
37.8% high complexity
59.8% medium
2.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,984
Total received (2018-2024)
Avg $2,569/year across 7 years
Top 28% in FL for medical oncology
87
Companies
619
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,397 (63.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,361 (24.3%)
Other
Charitable contributions, space rental, and other categories
$1,475 (8.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$750 (4.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$6,755
2023$2,824
2022$3,006
2021$1,224
2020$1,638
2019$1,307
2018$1,230
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PharmaEssentia USA Corporation
$2,711
Novartis Pharmaceuticals Corporation
$2,383
CTI BioPharma Corp.
$1,342
Adaptive Biotechnologies Corporation
$888
Celgene Corporation
$861
AstraZeneca Pharmaceuticals LP
$822
PFIZER INC.
$501
Janssen Biotech, Inc.
$473
Seagen Inc.
$437
Lilly USA, LLC
$422
Rigel Pharmaceuticals, Inc.
$395
Daiichi Sankyo Inc.
$390
Merck Sharp & Dohme Corporation
$371
Gilead Sciences, Inc.
$339
Genentech USA, Inc.
$309
Incyte Corporation
$284
GENZYME CORPORATION
$271
Amgen Inc.
$266
E.R. Squibb & Sons, L.L.C.
$260
Astellas Pharma US Inc
$239
Merck Sharp & Dohme LLC
$234
GlaxoSmithKline, LLC.
$232
Exelixis Inc.
$222
CSL Behring
$163
Stryker Corporation
$149
Eisai Inc.
$129
Takeda Pharmaceuticals U.S.A., Inc.
$129
Astellas Pharma Global Development
$125
ABBVIE INC.
$122
Ipsen Biopharmaceuticals, Inc
$115
ARRAY BIOPHARMA INC
$106
TerSera Therapeutics LLC
$99
Mirati Therapeutics, Inc.
$98
Bayer HealthCare Pharmaceuticals Inc.
$98
TESARO, Inc.
$89
JAZZ PHARMACEUTICALS INC.
$84
Tempus AI, Inc
$84
EISAI INC.
$81
Pharmacosmos Therapeutics Inc.
$70
Deciphera Pharmaceuticals Inc.
$68
Boehringer Ingelheim Pharmaceuticals, Inc.
$62
ADC Therapeutics America, Inc.
$61
Regeneron Healthcare Solutions, Inc.
$60
AbbVie Inc.
$57
EMD Serono, Inc.
$57
AVEO Pharmaceuticals, Inc.
$52
TAIHO ONCOLOGY, INC.
$51
SpringWorks Therapeutics, Inc.
$51
PUMA BIOTECHNOLOGY, INC.
$50
Aurobindo Pharma USA, Inc.
$48
Sun Pharmaceutical Industries Inc.
$46
Lexicon Pharmaceuticals, Inc.
$45
Janssen Pharmaceuticals, Inc
$44
Pharmacyclics LLC, an AbbVie Company
$43
BeiGene USA, Inc.
$42
Heron Therapeutics, Inc.
$42
AbbVie, Inc.
$41
Jazz Pharmaceuticals Inc.
$40
Puma Biotechnology, Inc.
$39
Pharmacyclics LLC, An AbbVie Company
$37
Dova Pharmaceuticals
$37
Myriad Genetic Laboratories, Inc.
$36
COLOPLAST CORP
$36
Bayer Healthcare Pharmaceuticals Inc.
$24
Stemline Therapeutics Inc.
$24
Seattle Genetics, Inc.
$23
SOBI, INC
$23
Progenics Pharmaceuticals, Inc.
$23
MorphoSys, US Inc.
$23
Sumitomo Pharma America, Inc.
$22
Foundation Medicine, Inc.
$22
Legend Biotech USA Inc.
$21
Taiho Oncology, Inc.
$21
TG THERAPEUTICS, INC.
$19
Helsinn Therapeutics (U.S.), Inc.
$19
Myovant Sciences Inc.
$17
Agios Pharmaceuticals, Inc.
$17
Immunomedics, Inc.
$16
Kite Pharma, Inc.
$16
ImmunoGen, Inc.
$16
Karyopharm Therapeutics Inc.
$16
MEDIVATION FIELD SOLUTIONS LLC
$16
Verity Pharmaceuticals Inc.
$15
Kyowa Kirin, Inc.
$15
GE HEALTHCARE
$14
R-Pharm US LLC
$13
Acrotech Biopharma LLC
$11
Top 3 companies account for 35.8% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AKYNZEO · ALUNBRIG · Afstyla · Alecensa · Altis · Avastin · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMEND · ENHERTU · ERBITUX · Elahere · Enhertu · Erleada · FOTIVDA · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Idelvion · Imbruvica · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYLARIFY · PYRUKYND · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPINEJACK · SUSTOL · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TEVIMBRA · TIVDAK · TUKYSA · Tavalisse · Trelstar · Trodelvy · UKONIQ · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · Xermelo · YONSA · YONSA (abiraterone acetate) · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (63%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $5 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
60
Per 100K population
6.2
County median income
$70,293
Nearest hospital
MORTON PLANT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Jooma is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Jooma experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Jooma performed 125,460 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jooma receive payments from pharmaceutical companies?
Yes. Dr. Jooma received a total of $17,984 from 87 companies across 619 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jooma's costs compare to other medical oncologys in Clearwater?
Dr. Jooma's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jooma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Clearwater
Browse medical oncologys in Clearwater ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
PharmaEssentia USA Corporation Payments to Doctors
See all physicians who received payments from PharmaEssentia USA Corporation.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
CTI BioPharma Corp. Payments to Doctors
See all physicians who received payments from CTI BioPharma Corp..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology